Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jack Williams

Showing results (51-60 of 55) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 55 results.
Vaccine|January 26, 2006
A clinical trial of prime-boost immunisation with the candidate malaria vaccines RTS,S/AS02A and MVA-CSSusanna J Dunachie, Michael Walther, Jenni M Vuola, et al.
Health Technology Assessment (Winchester, England)|October 19, 2021
A high-dose 24-hour tranexamic acid infusion for the treatment of significant gastrointestinal bleeding: HALT-IT RCTIan Roberts, Haleema Shakur-Still, Adefemi Afolabi, et al.
Vaccine|September 14, 2013
First-in-human evaluation of genetically attenuated Plasmodium falciparum sporozoites administered by bite of Anopheles mosquitoes to adult volunteersMichele Spring, Jittawadee Murphy, Robin Nielsen, et al.
Vaccine|September 10, 2009
Recombinant Liver Stage Antigen-1 (LSA-1) formulated with AS01 or AS02 is safe, elicits high titer antibody and induces IFN-gamma/IL-2 CD4+ T cells but does not protect against experimental Plasmodium falciparum infectionJames F Cummings, Michele D Spring, Robert J Schwenk, et al.
Nature|May 18, 2017
Extreme hydrothermal conditions at an active plate-bounding faultRupert Sutherland, John Townend, Virginia Toy, et al.
Pageof 6

Showing results (51-60 of 55) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 55 results.
Vaccine|January 26, 2006
A clinical trial of prime-boost immunisation with the candidate malaria vaccines RTS,S/AS02A and MVA-CSSusanna J Dunachie, Michael Walther, Jenni M Vuola, et al.
Health Technology Assessment (Winchester, England)|October 19, 2021
A high-dose 24-hour tranexamic acid infusion for the treatment of significant gastrointestinal bleeding: HALT-IT RCTIan Roberts, Haleema Shakur-Still, Adefemi Afolabi, et al.
Vaccine|September 14, 2013
First-in-human evaluation of genetically attenuated Plasmodium falciparum sporozoites administered by bite of Anopheles mosquitoes to adult volunteersMichele Spring, Jittawadee Murphy, Robin Nielsen, et al.
Vaccine|September 10, 2009
Recombinant Liver Stage Antigen-1 (LSA-1) formulated with AS01 or AS02 is safe, elicits high titer antibody and induces IFN-gamma/IL-2 CD4+ T cells but does not protect against experimental Plasmodium falciparum infectionJames F Cummings, Michele D Spring, Robert J Schwenk, et al.
Nature|May 18, 2017
Extreme hydrothermal conditions at an active plate-bounding faultRupert Sutherland, John Townend, Virginia Toy, et al.
Pageof 6